Pacira BioSciences, Inc. PCRX 17.03 Pacira BioSciences, Inc.

Home
⇒ 
Stock List ⇒ Pacira BioSciences, Inc.
Range:11.16-35.95Vol Avg:1264068Last Div:0Changes:0.71
Beta:0.84Cap:0.75BCurrency:USDExchange:NASDAQ
Sector:HealthcareIPO:Thu Feb 03 2011Empoloyees:711
CUSIP:695127100CIK:0001396814ISIN:US6951271005Country:US
CEO:Mr. Frank D. LeeWebsite:https://www.pacira.com
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow